As COVID-19 continues to ravage health systems across the world we are still asking ourselves what are the risks for stroke patients that have contracted COVID-19. Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke,

Antagonizing Dabigatran by Idarucizumab in Cases of Ischemic Stroke or Intracranial Hemorrhage in Germany – Updated Series of 120 Cases: Pawel Kermer

Aug 25th, 2020 13m 3s

Idarucizumab is a monoclonal antibody fragment with high affinity for dabigatran reversing its anticoagulant effects within minutes. Patients with acute ischemic stroke on dabigatran treatment may become eligible for thrombolysis with rt-PA. In

Mobile Stroke Unit versus standard medical care in the management of patients with acute stroke with Dr. Nida Fatima

Aug 19th, 2020 19m 34s

Mobile stroke units, otherwise known as MSUs have recently been introduced in the care of patients suspected of having an acute stroke, leading to shortening in the time to thrombolytics, but how does the clinical effectiveness in terms of func

Preceding Infection and Risk of Stroke: An Old Concept Revived by the COVID-19 Pandemic

Jul 30th, 2020 19m 22s

Anecdotal reports and clinical observations have recently emerged suggesting a relationship between COVID-19 disease and stroke; highlighting the possibility that infected individuals may be more susceptible to cerebrovascular eventsCarmen Lah

Structural integrity of white matter tracts as a predictor of acute ischemic stroke outcome

Jul 21st, 2020 17m

Clinical assessment scores in acute ischemic stroke are only moderately correlated with lesion volume since lesion location is an important confounding factor. Many studies have investigated grey matter indicators of stroke severity but the und

Taking Charge after stroke with Harry McNaughton

Jun 19th, 2020 23m 48s

In health research we often hear, and pay lip service to the term ‘patient centred‘. Many of us would probably be hard pressed to devise entirely patient centred studies. "Take Charge’ is an impressive, novel, community-based self-directed reha

The SAVE trial: sleep and stroke. Jingwei Li

May 27th, 2020 14m 11s

Controversy and great interest exists regarding cardiovascular and cerebrovascular risk and it’s relationship to sleep duration. Carmen Lahiff-Jenkins, Managing Editor of the International Journal of Stroke spoke to Dr Jingwei Li from the Georg

qTICI: Quantitative assessment of brain tissue reperfusion on digital subtraction angiograms of acute ischemic stroke patients

May 13th, 2020 25m 36s

The thrombolysis in cerebral infarction scale otherwise known as the (TICI) scale is an important outcome measure to evaluate the quality of endovascular stroke therapy. The TICI scale is ordinal and observer dependent, so this means it may not

Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19)

Apr 22nd, 2020 14m 24s

Coronavirus disease 2019 (COVID-19) is an ongoing pandemic characterized by high morbidity and mortality. Clinical factors that can identify patients at risk for worse outcomes can help in developing risk stratification models for judicious use

Management of Acute Ischemic Stroke in Patients with COVID-19 Infection

Apr 22nd, 2020 38m 36s

On March 11th, 2020 the World Health Organization declared the COVID-19 infection a pandemic. We are currently in the throws of that global infection and the big question everyone is racing to ask and answer is the risk of ischemic stroke highe

Sleep for Stroke Management and Recovery Trial (Sleep SMART): Rationale and methods

Mar 30th, 2020 10m 10s

Obstructive sleep apnea is common among patients with acute ischemic stroke and is associated with reduced functional recovery and an increased risk for recurrent vascular events. The Sleep SMART trial is the first large trial to test whether a

Peter Knapp on Frequency of anxiety after stroke: an updated systematic review and meta-analysis of observational studies

Mar 2nd, 2020 15m 39s

Thank you for listening to our podcast produced by the International Journal of Stroke! To help us spread the word please share with your colleagues, on twitter and if you are feeling particularly energised we’d love it if you would write a rev

Valery Feigin: Measuring stroke and transient ischaemic attack burden in New Zealand: protocol for the fifth Auckland Regional Community Stroke Study (ARCOS V)

Feb 20th, 2020 16m 16s

In 2017, for the first time, stroke, became the second most common cause of both death and disability in the world. In New Zealand (NZ) the situation is even more dire as was previously shown through a series of population-based Auckland Regio

Informal caregivers in stroke: life impact, support and psychological well-being - a Swedish Stroke Register (Riksstroke) study with Stefan Sennfalt

Dec 16th, 2019 11m 26s

Informal caregivers in stroke: life impact, support and psychological well-being - a Swedish Stroke Register (Riksstroke) studyIn 2016, the Swedish Stroke Register, Riksstroke, conducted a long-term follow-up survey on caregivers to patients w

Stroke and Cardiovascular Disease Control Act, Japan

Nov 25th, 2019 42m 13s

In this podcast World Stroke Organization members from Japan demonstrate the importance of professional and patient collaboration in influencing stroke policy. We spoke to people from Australia to Japan and followed the journey of this importan

A stroke recovery trial development framework: Consensus based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable with Professor Julie Bernhardt

Oct 28th, 2019 17m 28s

In 2015 discussions began among key researchers in the field of stroke rehabilitation and recovery. This resulted in the Stroke Recovery and Rehabilitation Roundtable who met in Philadelphia, in the USA and resulted in the publication of 6 pape

Standardized measurement of quality of upper limb movement after stroke: Consensus-based core recommendations from the Second Stroke Recovery and Rehabilitation Roundtable with Gert Kwakkel

Oct 28th, 2019 16m 3s

Moving stroke rehabilitation research evidence to clinical practice: Consensus-based core recommendations from the Stroke Recovery and Rehabilitation Roundtable with Professor Janice Eng

Oct 28th, 2019 12m 43s

Cognition in stroke rehabilitation and recovery research: Consensus-based core recommendations from the second Stroke Recovery and Rehabilitation Roundtable with Dr Michael O'Sullivan

Oct 28th, 2019 15m 43s

Dr George Ntaois on 'Oral anticoagulation versus antiplatelet/placebo for stroke prevention in patients with heart failure and sinus rhythm'

Oct 15th, 2019 12m 19s

Dr George Ntaois on 'Oral anticoagulation versus antiplatelet/placebo for stroke prevention in patients with heart failure and sinus rhythm: systematic review and meta-analysis of randomized controlled trials'Previous meta-analyses of randomiz

Dr Elena Pizzo on the Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke

Aug 1st, 2019 8m 14s

Cost-utility analysis of mechanical thrombectomy between 6 and 24 hours in acute ischemic stroke Recently, two randomized controlled trials demonstrated the benefit of mechanical thrombectomy performed between 6 and 24 hours in acute ischemic

Cerebral microbleeds: beyond the microscope. Vincent Berezowski

Jul 17th, 2019 9m 57s

Cerebral microbleeds: beyond the macroscope Deciphering the biological mechanisms leading to, or following microbleeds would enable us to address a key question: do microbleeds arise and impact the surrounding parenchyma like a miniature versi

Prof. Rustam Al-Shahi Salman REstart or STop Antithrombotics Randomised Trial for oral anticoagulants

Jun 4th, 2019 3m 14s

REstart or STop Antithrombotics Randomised Trial for oral anticoagulants. We talked results with Prof. Rustam Al-Shahi Salman from the University of Edinburgh.

Drs. Shelia Martins and Raul Nogueira RESILIENT trial

Jun 4th, 2019 4m 51s

EndoVascular Treatment With Stent-retriever and/or Thromboaspiration vs. Best Medical Therapy in Acute Ischemic Stroke (RESILIENT) Drs. Shelia Martins and Raul Nogueira RESULTS!https://clinicaltrials.gov/ct2/show/NCT02216643